Exscientia

Curated by Signal

Developer of AI-based platform for drug discovery platform

Overview

Developer of AI-based platform for drug discovery platform. It offers precision oncology platform and test AI-designed drug candidates against patient tissue models for small molecule drug design and lead optimization activities. It offers a pipeline of drug candidates for solid tumors, inflammatory disease, acute myeloid leukaemia, small-cell lung cancer, and haematology.

Key facts

Founded: 2012
Headquarters: Oxford, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

The Anti-Inflammaging Company
AI-based health risk assessment platform
Health TechnologyGrantham, United Kingdom
Assisi
Provider of solutions for veterinary practice management
Health TechnologyCrewe, United Kingdom
Mediscan
AI-based financial administration platform for healthcare organizations
Health TechnologyLondon, United Kingdom

About Exscientia

What does Exscientia do?

Developer of AI-based platform for drug discovery platform.

Where is Exscientia headquartered?

Exscientia is headquartered in Oxford, United Kingdom.

When was Exscientia founded?

Exscientia was founded in 2012.

Which sector is Exscientia in?

Exscientia operates in Health Technology.

Who are Exscientia's competitors?

Companies similar to Exscientia include The Anti-Inflammaging Company, Assisi, and Mediscan.